Prognostic significance of β-catenin expression in patients with ovarian cancer: A meta-analysis.

  title={Prognostic significance of $\beta$-catenin expression in patients with ovarian cancer: A meta-analysis.},
  author={Huideng Long and Ganxiong Li and Xiaoman Wen and Yanmin Lv and Min Zhang and Yuanfeng Wei and Wenting Xie and P-Y Zhong and Lijuan Pang},
Prognostic utility of the ovarian cancer secretome: a systematic investigation
A panel of seven promising secretory biomarkers associated with ovarian cancer prognosis is proposed and a search for relevant studies in the past 2 years was conducted in PubMed and a comprehensive list of proteins associated with the ovariancancer prognosis was prepared.
Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells
Light is shed on the mechanisms by which metformin may suppress tumour growth in EOC and it is suggested that met formin should be considered as a possible complementary therapy in E OC treatment.
Survival-associated transcriptome analysis in ovarian cancer
This paper presents a monograph on “Gynecology and Obstetrics of Women’s Gynaecology in Nanjing: Foundations of a Post-operative Caesarean Section”, published in 2016 by Nanjing University Medical School and the Chinese Academy of Medical Sciences.
Construction of novel multifunctional luminescent nanoparticles based on DNA bridging and their inhibitory effect on tumor growth
Cyclic RGD peptide was introduced onto the surface of silver nanoparticle (AgNP)-single strand DNA (ssDNA)-graphene quantum dots (GQDs) (ADG) after coating with a hybrid phospholipid material


Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.
The meta-analysis suggested that membranous, cytoplasmic and nuclear β-catenin all could serve as an important prognosticator for patients with NSCLC.
Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma
It is suggested that &bgr;-catenin overexpression in the nucleus or reduced expression in the membrane, but not its overexpressive in cytoplasm, could serve as a valuable prognostic predictor for CRC.
Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis
Cytoplasmic and/or nuclear accumulation of β-catenin, as an independent prognostic factor, is significantly associated with poor prognosis and deeper invasion of HCC, and could serve as a valuable prognostic predictor for HCC.
Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.
Expression of β-catenin and cyclinD1 may be used as predict markers for poor prognosis in ovarian serous carcinoma patients with immunohistochemical staining.
Loss of β-Catenin Is Associated With Poor Survival in Ovarian Carcinomas
The catenins (α-, β- and γ-) are cytoplasmic proteins that bind to the conserved tail of the epithelial cadherin molecule. The function of epithelial cadherin at the adherens junctions is dependent
Low membranous expression of β-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary
It is found that a low membranous expression of β-catenin and a high mitotic count were significantly associated with poor prognosis and early recurrence of ovarian endometrioid carcinoma and the GOG grading system showed no prognostic value.
Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast
Higher expression of cyclin D1, β-catenin, and MTA1 mRNAs in breast cancers may prove effective in predicting unfavorable outcomes of breast cancer.
Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer
The correlation between nuclear β-Catenin and CD44 indicates that β-catenin may regulate the transcription of CD44 in epithelial ovarian cancer, but these univariate associations were not strong enough to compete for significance with the traditional clinicopathological factors.